KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Consolidated Net Income (2016 - 2026)

Evolent Health has reported Consolidated Net Income over the past 12 years, most recently at -$429.2 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income fell 1780.37% year-over-year to -$429.2 million; the TTM value through Dec 2025 reached -$534.6 million, down 766.68%, while the annual FY2025 figure was -$534.5 million, N/A changed from the prior year.
  • Consolidated Net Income for Q4 2025 was -$429.2 million at Evolent Health, down from -$20.9 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $1.6 million in Q2 2024 and troughed at -$429.2 million in Q4 2025.
  • A 5-year average of -$52.0 million and a median of -$20.0 million in 2023 define the central range for Consolidated Net Income.
  • Biggest five-year swings in Consolidated Net Income: surged 621.89% in 2021 and later plummeted 1780.37% in 2025.
  • Year by year, Consolidated Net Income stood at -$8.7 million in 2021, then skyrocketed by 94.68% to -$463000.0 in 2022, then plummeted by 4215.77% to -$20.0 million in 2023, then fell by 14.22% to -$22.8 million in 2024, then plummeted by 1780.37% to -$429.2 million in 2025.
  • Business Quant data shows Consolidated Net Income for EVH at -$429.2 million in Q4 2025, -$20.9 million in Q3 2025, and -$19.9 million in Q2 2025.